Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Sulfasalazine"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 245
Tytuł:
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
Autorzy:
Tarkiainen M; Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland. .; Pediatric Research Center, University of Helsinki, Helsinki, Finland. .; HUS, P.O. Box 705, 00029, Helsinki, Finland. .
Tynjälä P; Poison Information Centre, Helsinki University Central Hospital, Helsinki, Finland.
Vähäsalo P; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Kröger L; Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.
Aalto K; Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.
Lahdenne P; Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2019 Dec 16; Vol. 17 (1), pp. 80. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Quality of Life*
Antirheumatic Agents/*therapeutic use
Arthritis, Juvenile/*drug therapy
Hydroxychloroquine/*therapeutic use
Infliximab/*therapeutic use
Methotrexate/*therapeutic use
Sulfasalazine/*therapeutic use
Adolescent ; Antirheumatic Agents/administration & dosage ; Child ; Drug Therapy, Combination ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Infliximab/administration & dosage ; Male ; Methotrexate/administration & dosage ; Sulfasalazine/administration & dosage ; Surveys and Questionnaires ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.
Autorzy:
Wabe N; School of Pharmacy and Medical Sciences and Sansom Institute for Health Research, Adelaide, South Australia, Australia.
Wojciechowski J; School of Pharmacy and Medical Sciences and Sansom Institute for Health Research, Adelaide, South Australia, Australia.; Australian Centre for Pharmacometrics, University of South Australia, Adelaide, South Australia, Australia.
Wechalekar MD; Rheumatology Unit, Repatriation General Hospital, Adelaide, South Australia, Australia.
Cleland LG; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
McWilliams L; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Lee A; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Proudman S; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Wiese MD; School of Pharmacy and Medical Sciences and Sansom Institute for Health Research, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2017 Oct; Vol. 20 (10), pp. 1447-1456. Date of Electronic Publication: 2017 Sep 26.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Medication Adherence*
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Hydroxychloroquine/*administration & dosage
Methotrexate/*administration & dosage
Sulfasalazine/*administration & dosage
Adult ; Aged ; Antirheumatic Agents/adverse effects ; Arthritis, Rheumatoid/diagnosis ; Chi-Square Distribution ; Disease Progression ; Drug Therapy, Combination ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Kaplan-Meier Estimate ; Linear Models ; Longitudinal Studies ; Male ; Methotrexate/adverse effects ; Middle Aged ; Multivariate Analysis ; Remission Induction ; Risk Factors ; Sulfasalazine/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Autorzy:
Hissink Muller PC; Department of Pediatrics/Pediatric Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. .; Department of Pediatrics/Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands. .
Brinkman DM; Department of Pediatrics/Pediatric Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pediatrics, Alrijne Hospital Leiderdorp, Leiderdorp, The Netherlands.
Schonenberg D; Department of Pediatric Hematology, Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands.
Koopman-Keemink Y; Department of Pediatrics, Hagaziekenhuis Juliana Children's Hospital, The Hague, The Netherlands.
Brederije IC; Department of Pediatrics/Pediatric Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Bekkering WP; Department of Pediatrics/Pediatric Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Kuijpers TW; Department of Pediatric Hematology, Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands.
van Rossum MA; Department of Pediatric Rheumatology, Amsterdam Rheumatology and Immunology Center location Reade Amsterdam, Amsterdam, The Netherlands.
van Suijlekom-Smit LW; Department of Pediatrics/Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
van den Berg JM; Department of Pediatric Hematology, Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands.
Allaart CF; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Ten Cate R; Department of Pediatrics/Pediatric Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2017 Feb 06; Vol. 15 (1), pp. 11. Date of Electronic Publication: 2017 Feb 06.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Antirheumatic Agents/*administration & dosage
Arthritis, Juvenile/*drug therapy
Methotrexate/*administration & dosage
Sulfasalazine/*administration & dosage
Administration, Oral ; Antirheumatic Agents/adverse effects ; Child ; Child, Preschool ; Drug Administration Schedule ; Drug Substitution ; Drug Therapy, Combination ; Etanercept/administration & dosage ; Etanercept/adverse effects ; Female ; Humans ; Injections, Subcutaneous ; Male ; Methotrexate/adverse effects ; Sulfasalazine/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
Autorzy:
Tam HW; School of Medicine, Chung Shan Medical University, Tai Chung, Taiwan.
Chen CM; Institute of Public Health, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Leong PY; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Tai Chung, Taiwan.; Institute of Medicine, Chung Shan Medical University Hospital, Tai Chung, Taiwan.
Chen CH; School of Medicine, Chung Shan Medical University, Tai Chung, Taiwan.
Li YC; School of Medicine, Chung Shan Medical University, Tai Chung, Taiwan.
Wang YH; Department of Medical Research, Chung Shan Medical University Hospital, Tai Chung, Taiwan.
Lin LC; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Tai Chung, Taiwan.; Institute of Medicine, Chung Shan Medical University Hospital, Tai Chung, Taiwan.; Department of Statistics, Oklahoma State University, Stillwater, OK, USA.
Chiou JY; School of Health Policy and Management, Chung Shan Medical University, Tai Chung, Taiwan.
Wei JC; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Tai Chung, Taiwan.; Institute of Medicine, Chung Shan Medical University Hospital, Tai Chung, Taiwan.; Institute of Integrative Medicine, China Medical University, Tai Chung, Taiwan.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2018 Aug; Vol. 21 (8), pp. 1591-1599. Date of Electronic Publication: 2018 Jan 25.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*administration & dosage
Stroke/*prevention & control
Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/epidemiology ; Databases, Factual ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Incidence ; Male ; Middle Aged ; Protective Factors ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/epidemiology ; Sulfasalazine/administration & dosage ; Taiwan/epidemiology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.
Autorzy:
Kuijper TM; a Department of Rheumatology , Maasstad Hospital , Rotterdam , The Netherlands.; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
Luime JJ; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
Xiong H; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.; c Institute of Health Policy and Management , Erasmus University , Rotterdam , The Netherlands.
de Jong P; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
van der Lubbe P; d Department of Rheumatology , Vlietland Hospital , Schiedam , The Netherlands.
van Zeben D; e Department of Rheumatology , St Franciscus Hospital , Rotterdam , The Netherlands.
Tchetverikov I; f Department of Rheumatology , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
Hazes J; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
Weel A; a Department of Rheumatology , Maasstad Hospital , Rotterdam , The Netherlands.; b Department of Rheumatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
Pokaż więcej
Źródło:
Scandinavian journal of rheumatology [Scand J Rheumatol] 2018 May; Vol. 47 (3), pp. 178-184. Date of Electronic Publication: 2017 Oct 02.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anxiety/*psychology
Arthritis, Rheumatoid/*complications
Depression/*psychology
Glucocorticoids/*therapeutic use
Methotrexate/*therapeutic use
Monitoring, Physiologic/*methods
Sulfasalazine/*therapeutic use
Antirheumatic Agents/therapeutic use ; Anxiety/etiology ; Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/psychology ; Depression/etiology ; Disease Progression ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.
Autorzy:
Vermeer M
Kievit W
Kuper HH; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands. .
Braakman-Jansen LM
Bernelot Moens HJ
Zijlstra TR
den Broeder AA
van Riel PL
Fransen J
van de Laar MA
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2013 Dec 13; Vol. 14, pp. 350. Date of Electronic Publication: 2013 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Registries*
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*administration & dosage
Sulfasalazine/*administration & dosage
Adult ; Aged ; Antirheumatic Agents/economics ; Arthritis, Rheumatoid/economics ; Cost-Benefit Analysis ; Female ; Follow-Up Studies ; Humans ; Male ; Methotrexate/economics ; Middle Aged ; Remission Induction ; Sulfasalazine/economics ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial.
Autorzy:
Levitsky A; a Department of Medicine, Solna, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.
Forslind K; b Department of Internal Medicine , Section of Rheumatology, Helsingborg Hospital , Sweden.; c Department of Clinical Sciences , Section of Rheumatology, Lund University , Sweden.
van Vollenhoven RF; a Department of Medicine, Solna, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.
Pokaż więcej
Corporate Authors:
SWEFOT trial group
Źródło:
Scandinavian journal of rheumatology [Scand J Rheumatol] 2015; Vol. 44 (5), pp. 348-53. Date of Electronic Publication: 2015 May 20.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Disease Progression*
Arthritis, Rheumatoid/*diagnostic imaging
Arthritis, Rheumatoid/*drug therapy
Hydroxychloroquine/*therapeutic use
Infliximab/*therapeutic use
Methotrexate/*therapeutic use
Sulfasalazine/*therapeutic use
Adult ; Aged ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Radiography ; Severity of Illness Index ; Sweden ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Autorzy:
Boers M; University Hospital Maastricht, The Netherlands.
Verhoeven AC
Markusse HM
van de Laar MA
Westhovens R
van Denderen JC
van Zeben D
Dijkmans BA
Peeters AJ
Jacobs P
van den Brink HR
Schouten HJ
van der Heijde DM
Boonen A
van der Linden S
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 1997 Aug 02; Vol. 350 (9074), pp. 309-18.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Inflammatory Agents/*administration & dosage
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*administration & dosage
Prednisolone/*administration & dosage
Sulfasalazine/*administration & dosage
Adult ; Anti-Inflammatory Agents/adverse effects ; Antirheumatic Agents/adverse effects ; Arthritis, Rheumatoid/diagnostic imaging ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Humans ; Male ; Methotrexate/adverse effects ; Middle Aged ; Prednisolone/adverse effects ; Radiography ; Sulfasalazine/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekstSzczegóły
Tytuł:
Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
Autorzy:
Can M; Department of Rheumatology, Pendik Training and Research Hospital, Marmara University, Istanbul, Turkey. />Aydın SZ
Niğdelioğlu A
Atagündüz P
Direskeneli H
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2012 Dec; Vol. 15 (6), pp. 526-30. Date of Electronic Publication: 2012 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Antirheumatic Agents/*therapeutic use
Biological Products/*therapeutic use
Methotrexate/*therapeutic use
Spondylitis, Ankylosing/*drug therapy
Sulfasalazine/*therapeutic use
Adult ; Biomarkers/blood ; Blood Sedimentation ; C-Reactive Protein/analysis ; Drug Substitution ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Spondylitis, Ankylosing/diagnosis ; Spondylitis, Ankylosing/immunology ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Medical therapy: where are we now?
Autorzy:
Resman-Targoff BH; Department of Pharmacy, Clinical and Administrative Sciences, The University of Oklahoma College of Pharmacy, P.O. Box 26901, Oklahoma City, OK 73190, USA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2006 Sep 15; Vol. 63 (18 Suppl 4), pp. S11-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*therapeutic use
Drug Therapy, Combination ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Isoxazoles/adverse effects ; Isoxazoles/therapeutic use ; Leflunomide ; Methotrexate/adverse effects ; Sulfasalazine/adverse effects ; Sulfasalazine/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
Autorzy:
Biswal BK; Stem Cell and Molecular Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, Chennai-600036, India.
Verma RS
Pokaż więcej
Źródło:
Journal of biochemistry [J Biochem] 2009 Nov; Vol. 146 (5), pp. 693-703. Date of Electronic Publication: 2009 Aug 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Folic Acid/*metabolism
Leukemia/*metabolism
Leukemia/*pathology
Methotrexate/*metabolism
T-Lymphocytes/*metabolism
Antibodies/pharmacology ; Biological Transport/drug effects ; Buffers ; Carrier Proteins/genetics ; Carrier Proteins/immunology ; Carrier Proteins/metabolism ; Cell Line, Tumor ; Folate Receptors, GPI-Anchored ; Folic Acid/analogs & derivatives ; Gene Expression Regulation/drug effects ; Humans ; Hydrogen-Ion Concentration/drug effects ; Immunohistochemistry ; Ions ; Membrane Transport Proteins/genetics ; Membrane Transport Proteins/metabolism ; Methotrexate/analogs & derivatives ; Mitomycin/pharmacology ; Phosphates/metabolism ; Receptors, Cell Surface/genetics ; Receptors, Cell Surface/immunology ; Receptors, Cell Surface/metabolism ; Reduced Folate Carrier Protein ; Reverse Transcriptase Polymerase Chain Reaction ; Sulfasalazine/pharmacology ; Sulfates/metabolism ; T-Lymphocytes/drug effects ; Time Factors ; Verapamil/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
Autorzy:
Teraki Y
Izaki S
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2009 Oct; Vol. 34 (7), pp. e287-8. Date of Electronic Publication: 2009 May 05.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Antirheumatic Agents/*adverse effects
Drug Eruptions/*etiology
Immunosuppressive Agents/*adverse effects
Methotrexate/*adverse effects
Sulfasalazine/*adverse effects
Arthritis, Rheumatoid/drug therapy ; Drug Therapy, Combination ; Female ; Humans ; Middle Aged
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
Autorzy:
Nikolaisen C; Department of Rheumatology at Institute of Clinical Medicine, University of Tromsø, Norway.
Kvien TK
Mikkelsen K
Kaufmann C
Rødevand E
Nossent JC
Pokaż więcej
Źródło:
Scandinavian journal of rheumatology [Scand J Rheumatol] 2009; Vol. 38 (4), pp. 240-5.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*diagnosis
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*therapeutic use
Sulfasalazine/*therapeutic use
Adult ; Age Factors ; Aged ; Cohort Studies ; Confidence Intervals ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Early Diagnosis ; Female ; Follow-Up Studies ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Norway ; Odds Ratio ; Pain Measurement ; Probability ; Risk Assessment ; Sex Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rheumatoid arthritis: not yet curable with early intensive therapy.
Autorzy:
Emery P; Rhaumatology and Rehabilitation Research Unit, University of Leads, UK.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 1997 Aug 02; Vol. 350 (9074), pp. 304-5.
Typ publikacji:
Comment; Journal Article
MeSH Terms:
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Methotrexate/*administration & dosage
Prednisolone/*administration & dosage
Sulfasalazine/*administration & dosage
Anti-Inflammatory Agents/administration & dosage ; Drug Therapy, Combination ; Humans
Czasopismo naukowe
Pełny tekstSzczegóły
Wyświetlanie 1-20 z 245

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies